Retatrutide is classified as a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors), making it more effective for body fat mass reduction than its predecessor Semaglutide by targeting further receptors
You know why BPC-157 doesnt have it
AOD-9604 Peptide Therapy involves administering the AOD-9604 peptide to support fat metabolism through targeted receptor activation
Expression and localization of v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma
Despite its unlicensed status, retatrutide is increasingly being sold online often marketed as a 'research peptide' and some individuals are obtaining it outside regulated medical channels
From a clinical standpoint, peptides play an important role in areas like metabolic health, hormone balance, and weight management